PHARMACEUTICALS 2012 - Method Validation in Drug Development Process - Common Mistakes and Issues

Website http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=702250?channel=ourglocal | Edit Freely

Category Method Validation; Drug Development; assay validation; setting specifications; reference standard; validation studies

Deadline: March 07, 2012 | Date: March 07, 2012

Venue/Country: Palo Alto, U.S.A

Updated: 2012-02-13 19:58:36 (GMT+9)

Call For Papers - CFP

This Method Validation training in drug development process will provide guidance in setting appropriate specifications, determining if the assay is validatable, and monitoring progress during the validation.

Why Should You Attend:

This webinar will address frequently observed issues and problems with method validations. Validated methods are required for Phase III of the drug development process. Moving methods from the development phase to the validated phase ready for sample analysis does not always occur without unforeseen issues arising. Differences in laboratories and analysts, as well as instrumentation can contribute to delays in validating methods.